8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2014 / Narrative review
This review details how obesity and related metabolic conditions contribute to hepatocarcinogenesis. Obesity-associated hepatocellular carcinoma is attributed to chronic inflammation from adipose remodeling, pro-inflammatory adipokine secretion, ectopic lipid accumulation, altered gut microbiota, disrupted stellate cell senescence, and insulin resistance with elevated insulin and insulin-like growth factors. These pathways synergize with chronic liver disease from other etiologies to accelerate hepatocellular carcinoma development.
Shows an association, not proof of cause and effect.
Karagozian R, Derdák Z, Baffy G Metabolism, 2014. PMID 24629562
2014 / Narrative review
This narrative review examined data on dietary sugar consumption and related health risks, including NHANES, USDA surveys, meta-analyses, and randomized controlled trials. About 75% of foods and beverages contain added sugar, and soft drink consumption has increased fivefold since 1950. Meta-analyses indicate sugar-sweetened beverage (SSB) intake is related to risks of diabetes, metabolic syndrome, and cardiovascular disease, and drinking two 16-ounce SSBs daily for 6 months induced metabolic syndrome features and fatty liver. Trials lasting 6 months to 2 years showed that lowering soft drink intake reduced weight gain.
Bray GA, Popkin BM Diabetes Care, 2014. PMID 24652725
2014 / Review
This review discusses the impact of iron overload on chronic metabolic diseases such as type 2 diabetes, obesity, non-alcoholic fatty liver disease, and atherosclerosis. Iron overload affects glucose and lipid metabolism in tissues like pancreatic β cells, liver, muscle, and adipose tissue, resulting in organ damage. Conversely, iron depletion can exert beneficial effects in patients with iron overload and in healthy frequent blood donors. The authors suggest regular assessment of iron balance for patients with chronic metabolic diseases.
Fernández-Real JM, Manco M Lancet Diabetes Endocrinol, 2014. PMID 24731656
2014 / Systematic review
A systematic review of 17 human or animal studies evaluated the relationship between dietary advanced glycation end products (AGEs) and inflammatory processes. Human intervention studies mainly showed a decrease in inflammation on a low-AGE diet, while an increase on a high-AGE diet was less apparent; about half of observational studies found a link. Overall, limiting dietary AGE intake may decrease inflammation and related chronic conditions, though most trials were in patients with diabetes or chronic kidney disease.
Van Puyvelde K, Mets T, Njemini R, et al. Nutr Rev, 2014. PMID 25231200
2014 / Narrative review
This review evaluated whether a strict vegan diet provides health advantages compared to vegetarian or overall healthy diets through the gut microbiota. Across studies, the relationship between diet and intestinal microbiota appears to follow a continuum, with vegans showing a microbiota profile most distinct from omnivores, though not always significantly different from vegetarians. The vegan profile uniquely showed a reduced abundance of pathobionts and greater abundance of protective species, with reduced inflammation proposed as a key linking feature. However, it remains unclear whether a therapeutic vegan diet can be prescribed to alter gut microflora for long-term health benefits.
Glick-Bauer M, Yeh MC Nutrients, 2014. PMID 25365383
2013 / Lecture / narrative review
This lecture discusses mechanisms underlying type 2 diabetes reversal. Findings from the Counterpoint study demonstrated that a very low calorie diet alone restored normal glucose levels and beta cell function. Magnetic resonance methods showed a rapid fall in liver fat and resolution of hepatic insulin sensitivity within days, followed by decreased pancreas fat and restored beta cell insulin secretion over weeks. The twin cycle hypothesis postulates that chronic calorie excess leads to intra-organ fat accumulation, indicating type 2 diabetes is a reversible condition of intra-organ fat excess.
Taylor R Diabet Med, 2013. PMID 23075228
2013 / Narrative review of clinical trials
This review examines clinical trials from the past quarter century addressing the pharmacokinetics, safety, and efficacy of curcumin in humans. Promising effects were noted in patients with diverse pro-inflammatory diseases, such as cancer, cardiovascular disease, arthritis, gastrointestinal conditions, diabetes, and renal diseases. Dose-escalating studies showed curcumin is safe at doses as high as 12 g/day over 3 months. Curcumin modulates numerous human signaling molecules, including pro-inflammatory cytokines, apoptotic proteins, NF-κB, COX-2, STAT3, C-reactive protein, and triglycerides.
Gupta SC, Patchva S, Aggarwal BB AAPS J, 2013. PMID 23143785
2013 / Narrative review
This review outlines nonalcoholic fatty liver disease (NAFLD), ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), noting obesity, insulin resistance, type 2 diabetes mellitus, and dyslipidemia as major risk factors. Weight loss is a cornerstone of therapy, where ~5% weight loss is believed to improve steatosis and ~10% is necessary to improve steatohepatitis. Pharmacologic agents like vitamin E and thiazolidinediones have also demonstrated promise in select patient subgroups.
Masuoka HC, Chalasani N Ann N Y Acad Sci, 2013. PMID 23363012
2013 / Narrative review
This review evaluates curcumin, a component of turmeric, as an alternative to expensive injectable TNF-α blockers approved for inflammatory conditions. The authors report that curcumin is orally bioavailable and highly safe in humans, and can block TNF-α production and action across in vitro models, animal models, and human studies. Evidence is discussed regarding curcumin's activity against diseases treated with TNF blockers, along with mechanisms inhibiting TNF production and signalling pathways.
Aggarwal BB, Gupta SC, Sung B Br J Pharmacol, 2013. PMID 23425071
2013 / Narrative review
This review evaluates the health impacts of sugar and high-fructose corn syrup consumed primarily through beverages. Most meta-analyses relate calorically sweetened beverage consumption to risks of obesity, diabetes, cardiovascular disease, metabolic syndrome, nonalcoholic fatty liver disease, and gout in men. Randomized trials showed that sugar or fructose alone increases triglycerides, body weight, visceral adipose tissue, muscle fat, and liver fat, with fructose enhancing lipogenesis and uric acid production.
Bray GA Adv Nutr, 2013. PMID 23493538
2013 / Narrative review
This review examines the roles of various lipid depots in human adiposity and insulin resistance. Intra-abdominal and liver fats are closely linked to insulin resistance, while intramyocellular triglyceride is associated with muscle insulin resistance despite anomalies in athletes and women. Subcutaneous fat, particularly gluteofemoral, appears metabolically protective, whereas pericardial and perivascular fats relate to atheromatous disease rather than insulin resistance. The metabolic importance of adult human brown adipose tissue under usual conditions remains unclear.
Shows an association, not proof of cause and effect.
Hocking S, Samocha-Bonet D, Milner KL, et al. Endocr Rev, 2013. PMID 23550081
2013 / Commentary / narrative review of a human trial
This commentary summarizes a human trial assessing the effects of whole grain barley, brown rice, or their combination on fecal microbiota and metabolic/inflammatory markers. Whole grain intake increased gut microbial diversity and induced compositional alterations. The combination of barley and brown rice reduced plasma interleukin-6 (IL-6), which was linked to compositional features of the gut microbiota.
Walter J, Martínez I, Rose DJ Gut Microbes, 2013. PMID 23645316
2013 / Narrative review
This review evaluates the potential and current evidence for whole grains influencing nonalcoholic fatty liver disease (NAFLD). While epidemiological studies link whole grain intake to lower risks of obesity and related conditions, the authors noted that no direct work had examined whole grains for preventing or treating fatty liver diseases. Due to their nutrient and phytochemical composition, switching from refined grains to whole grains should be considered in dietary guidelines for patients at risk of or diagnosed with fatty liver disease.
Ross AB, Godin JP, Minehira K, et al. Int J Endocrinol, 2013. PMID 23762052
2013 / Narrative review
This review examines the role of inflammation and oxidative and nitrosative stress as potential mediators of environmental risk factors for depression. The authors identify several factors associated with systemic inflammation that appear to increase the risk of depression, including psychosocial stressors, poor diet, physical inactivity, obesity, smoking, altered gut permeability, atopy, dental caries, sleep disturbances, and vitamin D deficiency. They conclude that because most of these inflammatory sources are plastic, they represent potential targets for preventative and therapeutic interventions.
Shows an association, not proof of cause and effect.
Berk M, Williams LJ, Jacka FN, et al. BMC Med, 2013. PMID 24228900
2013 / Narrative review
This review summarizes evidence evaluating the mechanisms of action of anthocyanins on hepatic lipid metabolism across in vitro, in vivo, and human trials. Anthocyanins are reported to decrease hepatic lipid accumulation and may counteract oxidative stress and hepatic inflammation, though their impact on NAFLD remains to be fully determined. Based on the literature, the authors propose a working model outlining the mechanisms behind these potential benefits.
Valenti L, Riso P, Mazzocchi A, et al. Oxid Med Cell Longev, 2013. PMID 24282628
2013 / Narrative review
This review explores the effects of maternal dietary polyphenols on the fetal ductus arteriosus during late pregnancy. The ductus arteriosus directs 80-85% of right ventricular output to the descending aorta, and constriction can cause complications such as heart failure, hydrops, neonatal pulmonary hypertension, and death. Evidence suggests that herbs, fruits, nuts, and polyphenol-rich foods possess anti-inflammatory actions that inhibit prostaglandin synthesis, potentially altering ductal flow dynamics during the third trimester.
Zielinsky P, Busato S Birth Defects Res C Embryo Today, 2013. PMID 24339037
2013 / Narrative review
This review evaluates the evidence surrounding deliberate and medically supervised modified fasting (200-500 kcal/day for 7-21 days) for disease prevention and treatment. Observational and empirical evidence suggests efficacy in rheumatic diseases, chronic pain syndromes, hypertension, and metabolic syndrome, with randomized controlled trials confirming benefits of fasting followed by a vegetarian diet in rheumatoid arthritis. Additionally, intermittent fasting is associated with deceleration or prevention of chronic degenerative diseases and may serve as an adjunct to cancer chemotherapy.
Michalsen A, Li C Forsch Komplementmed, 2013. PMID 24434759
2012 / Narrative review
This review examines literature regarding the role of diet and nutrient composition in managing nonalcoholic fatty liver disease (NAFLD). NAFLD is linked to insulin resistance and considered the hepatic manifestation of metabolic syndrome, with lifestyle modification focused on weight loss, exercise, and improved insulin sensitivity being key to treatment. Because specific dietary guidelines for NAFLD are lacking, the authors propose a dietary framework based on available evidence and guidelines aimed at reducing insulin resistance and cardiovascular risk.
McCarthy EM, Rinella ME J Acad Nutr Diet, 2012. PMID 22717200
2012 / Narrative review
This review summarizes evidence from in vitro, animal, and human studies on the antiatherogenic properties of dietary oats. Beyond lowering plasma total and LDL cholesterol via beta-glucans, oat micronutrients and phytochemicals may exert antioxidative and anti-inflammatory actions and help preserve endothelial function. The authors note that findings from in vitro assays using isolated components are hard to translate to whole oats, and highlight a lack of epidemiological studies examining oat intake across cardiovascular disease outcomes.
Andersson KE, Hellstrand P Mol Nutr Food Res, 2012. PMID 22764134
2012 / Evidence synthesis / narrative review
This paper synthesizes literature supporting that a Western diet and inactivity are proinflammatory, while a plant-based diet and physical activity are anti-inflammatory in the context of chronic osteoarthritis. The authors present evidence-informed recommendations for integrating lifestyle behavior change into first-line osteoarthritis care. They suggest healthy living may help reduce inflammation, oxidative stress, pain, and disability, as well as reduce weight and the need for medications and surgery.
Dean E, Gormsen Hansen R Arthritis, 2012. PMID 23346399
2011 / Narrative review
Low-grade systemic inflammation ('metaflammation') is tied to many chronic diseases and was initially suspected to stem causally from weight gain and obesity. While nutritive factors are common inducers, this review examines non-nutritive inflammatory triggers associated with modern post-industrial environments and lifestyles. The authors argue obesity may be neither necessary nor sufficient to explain the chronic disease epidemic, acting instead like a 'canary in the mineshaft' signaling widespread environmental issues.
Egger G, Dixon J Obes Rev, 2011. PMID 20701689
2011 / Narrative review
Metabolic syndrome has emerged as a major public health concern with an estimated prevalence of approximately 25% in the United States. It centers around central obesity, hypertension, low high-density lipoproteins, and elevated triglycerides, with insulin resistance as the uniting factor, and predicts the development of diabetes and cardiovascular disease. Nonalcoholic fatty liver disease represents its hepatic component, which can progress to nonalcoholic steatohepatitis (NASH). Weight loss through diet or bariatric surgery and vitamin E have recently been demonstrated as effective treatments for NASH.
McCullough AJ J Dig Dis, 2011. PMID 21091931
2011 / Narrative review
This review evaluates current and emerging therapeutic strategies for non-alcoholic fatty liver disease (NAFLD). Weight loss remains the cornerstone of treating hepatic steatosis, though it is difficult to achieve, and pragmatic approaches include general recommendations for weight loss and physical activity. Because insulin resistance is considered a pivotal factor in NAFLD and its progression, insulin sensitizers are viewed as a treatment of choice among pharmacotherapies.
Marchesini G, Moscatiello S, Agostini F, et al. Expert Opin Emerg Drugs, 2011. PMID 21352073
2011 / Narrative review
This narrative review evaluates the molecular-level effects of dietary molecules on inflammatory and autoimmune processes involved in multiple sclerosis (MS). The authors note that bioactive dietary components can shift cellular metabolism from anabolism to catabolism and down-regulate inflammation through interactions with enzymes, nuclear receptors, and transcription factors. Managing gut dysbiosis and combining hypo-caloric, low-fat diets with specific vitamins, oligoelements, fish oil, and polyphenols may help slow disease progression and improve patient wellness.
Riccio P Complement Ther Med, 2011. PMID 21827937